Image 1 of 1
TB-500 10 mg – Actin-Binding Research | Cell-Migration and Tissue-Remodelling Research | Premium Research Compound
A premium research compound supplied in a convenient 10 mg vial.
TB-500 is a synthetic peptide associated with the actin-binding region of thymosin beta-4. It is investigated in laboratory and preclinical research involving actin regulation, cell migration, angiogenic signalling, extracellular-matrix activity, inflammatory responses, and tissue-remodelling pathways.
What’s Included
1x TB-500 10 mg vial
Over 99% Purity
Premium-quality research compound
Shipped from the Gold Coast, Queensland
Australia Post Express Post
Why Choose TB-500 10 mg?
TB-500 is commonly identified as an N-terminally acetylated synthetic peptide corresponding to amino-acid residues 17–23 of thymosin beta-4.
Researchers investigate TB-500 in relation to:
Actin-binding mechanisms
Cytoskeletal organisation
Cell-migration pathways
Angiogenic signalling
Extracellular-matrix activity
Inflammatory-response pathways
Cellular differentiation
Tissue-remodelling processes
Its association with the active actin-binding region of thymosin beta-4 makes TB-500 an important compound for specialised cellular-migration, cytoskeletal, vascular-signalling, and tissue-remodelling research.
TB-500 Research
TB-500 is commonly investigated in laboratory and preclinical research relating to:
Actin sequestration and regulation
Cytoskeletal organisation
Cellular motility
Cell-migration mechanisms
Angiogenesis-associated pathways
Endothelial-cell activity
Extracellular-matrix remodelling
Cellular differentiation
Inflammatory signalling
Oxidative-stress responses
Fibroblast-associated activity
Experimental tissue-repair models
Research continues into how TB-500 and thymosin beta-4-associated sequences interact with actin and influence cell movement, vascular signalling, inflammatory responses, and tissue-remodelling processes.
Thymosin Beta-4 Fragment Research
The active region commonly associated with TB-500 corresponds to residues 17–23 of thymosin beta-4.
It is composed of the following N-terminally acetylated seven-amino-acid sequence:
Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln
Researchers investigate this specialised peptide sequence for its potential to:
Interact with actin-associated pathways
Influence cytoskeletal organisation
Support cell-migration research
Affect endothelial-cell activity
Influence angiogenic signalling
Assist investigation of extracellular-matrix processes
Support experimental tissue-remodelling models
Published research has identified the LKKTETQ region as an important actin-binding sequence within the larger thymosin beta-4 protein.
Available evidence remains primarily laboratory and preclinical. Further appropriately controlled research is required to establish the biological activity, safety, and characteristics of individual TB-500 research preparations.
Premium Research Compound. One Easy Order.
OZZ Peptides TB-500 10 mg provides researchers with a convenient option for investigating actin regulation, cellular migration, angiogenic signalling, extracellular-matrix activity, and tissue-remodelling pathways.
Securely packed and shipped directly from the Gold Coast using Australia Post Express Post.
Product Highlights
🧬 Actin-Binding Research
Investigated in laboratory studies involving actin regulation and cytoskeletal organisation.
🔬 Cell-Migration Research
Studied for its association with pathways influencing cellular movement and motility.
🩸 Angiogenic-Signalling Research
Used in preclinical models examining endothelial-cell activity and vascular signalling.
🧫 Tissue-Remodelling Research
Investigated in relation to extracellular-matrix activity and cellular remodelling processes.
🔄 Cellular-Response Research
Studied in experimental models involving cellular differentiation and stress responses.
🛡️ Inflammatory-Pathway Research
Investigated in relation to inflammatory signalling and cellular-response mechanisms.
💎 Over 99% Purity
Premium-quality research compound.
📦 Fast Australian Delivery
Sent using Australia Post Express Post.
🌴 Gold Coast Based
Packed and shipped by the OZZ Peptides team in Queensland.
What You’ll Receive
1x TB-500 10 mg vial
Securely packed for delivery
Australia Post Express Post
Storage
Store according to the storage information supplied with the product.
Before reconstitution, keep the vial in a cool, dry environment away from direct sunlight. After reconstitution, appropriate refrigerated storage may be required according to the supplier’s specifications and applicable laboratory protocol.
Important Information
Products supplied by OZZ Peptides are intended for laboratory research purposes only and are not intended for human or veterinary consumption, injection, injury recovery, muscle or tendon repair, performance enhancement, diagnosis, treatment, cure, or prevention of any disease.
TB-500 is an experimental research compound. Its safety and effectiveness for human use have not been established or approved in Australia.
Athlete warning: Thymosin beta-4 and its derivatives, including TB-500, are prohibited under the World Anti-Doping Agency Prohibited List. Competitive athletes should not use or handle this product outside properly authorised research settings.
A premium research compound supplied in a convenient 10 mg vial.
TB-500 is a synthetic peptide associated with the actin-binding region of thymosin beta-4. It is investigated in laboratory and preclinical research involving actin regulation, cell migration, angiogenic signalling, extracellular-matrix activity, inflammatory responses, and tissue-remodelling pathways.
What’s Included
1x TB-500 10 mg vial
Over 99% Purity
Premium-quality research compound
Shipped from the Gold Coast, Queensland
Australia Post Express Post
Why Choose TB-500 10 mg?
TB-500 is commonly identified as an N-terminally acetylated synthetic peptide corresponding to amino-acid residues 17–23 of thymosin beta-4.
Researchers investigate TB-500 in relation to:
Actin-binding mechanisms
Cytoskeletal organisation
Cell-migration pathways
Angiogenic signalling
Extracellular-matrix activity
Inflammatory-response pathways
Cellular differentiation
Tissue-remodelling processes
Its association with the active actin-binding region of thymosin beta-4 makes TB-500 an important compound for specialised cellular-migration, cytoskeletal, vascular-signalling, and tissue-remodelling research.
TB-500 Research
TB-500 is commonly investigated in laboratory and preclinical research relating to:
Actin sequestration and regulation
Cytoskeletal organisation
Cellular motility
Cell-migration mechanisms
Angiogenesis-associated pathways
Endothelial-cell activity
Extracellular-matrix remodelling
Cellular differentiation
Inflammatory signalling
Oxidative-stress responses
Fibroblast-associated activity
Experimental tissue-repair models
Research continues into how TB-500 and thymosin beta-4-associated sequences interact with actin and influence cell movement, vascular signalling, inflammatory responses, and tissue-remodelling processes.
Thymosin Beta-4 Fragment Research
The active region commonly associated with TB-500 corresponds to residues 17–23 of thymosin beta-4.
It is composed of the following N-terminally acetylated seven-amino-acid sequence:
Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln
Researchers investigate this specialised peptide sequence for its potential to:
Interact with actin-associated pathways
Influence cytoskeletal organisation
Support cell-migration research
Affect endothelial-cell activity
Influence angiogenic signalling
Assist investigation of extracellular-matrix processes
Support experimental tissue-remodelling models
Published research has identified the LKKTETQ region as an important actin-binding sequence within the larger thymosin beta-4 protein.
Available evidence remains primarily laboratory and preclinical. Further appropriately controlled research is required to establish the biological activity, safety, and characteristics of individual TB-500 research preparations.
Premium Research Compound. One Easy Order.
OZZ Peptides TB-500 10 mg provides researchers with a convenient option for investigating actin regulation, cellular migration, angiogenic signalling, extracellular-matrix activity, and tissue-remodelling pathways.
Securely packed and shipped directly from the Gold Coast using Australia Post Express Post.
Product Highlights
🧬 Actin-Binding Research
Investigated in laboratory studies involving actin regulation and cytoskeletal organisation.
🔬 Cell-Migration Research
Studied for its association with pathways influencing cellular movement and motility.
🩸 Angiogenic-Signalling Research
Used in preclinical models examining endothelial-cell activity and vascular signalling.
🧫 Tissue-Remodelling Research
Investigated in relation to extracellular-matrix activity and cellular remodelling processes.
🔄 Cellular-Response Research
Studied in experimental models involving cellular differentiation and stress responses.
🛡️ Inflammatory-Pathway Research
Investigated in relation to inflammatory signalling and cellular-response mechanisms.
💎 Over 99% Purity
Premium-quality research compound.
📦 Fast Australian Delivery
Sent using Australia Post Express Post.
🌴 Gold Coast Based
Packed and shipped by the OZZ Peptides team in Queensland.
What You’ll Receive
1x TB-500 10 mg vial
Securely packed for delivery
Australia Post Express Post
Storage
Store according to the storage information supplied with the product.
Before reconstitution, keep the vial in a cool, dry environment away from direct sunlight. After reconstitution, appropriate refrigerated storage may be required according to the supplier’s specifications and applicable laboratory protocol.
Important Information
Products supplied by OZZ Peptides are intended for laboratory research purposes only and are not intended for human or veterinary consumption, injection, injury recovery, muscle or tendon repair, performance enhancement, diagnosis, treatment, cure, or prevention of any disease.
TB-500 is an experimental research compound. Its safety and effectiveness for human use have not been established or approved in Australia.
Athlete warning: Thymosin beta-4 and its derivatives, including TB-500, are prohibited under the World Anti-Doping Agency Prohibited List. Competitive athletes should not use or handle this product outside properly authorised research settings.